Global Tuberculosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431597
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Bayer Healthcare
  • Eli Lilly & Co.
  • Labatec Pharma SA
  • Mylan N.V.
  • Novatis AG
  • Patheon, Inc.
  • MORE
Tuberculosis Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global tuberculosis treatment market was valued at US$ 838.4 Mn in 2016, and is expected to reach US$ 1,306.6 Mn by 2025 expanding at a CAGR of 4.9% from 2017 to 2025.

Market Insights

About one third of the worlds’s population is suffering with latent tuberculosis, people infected with mycobacterium infection have a 10% risk to fall ill with tuberculosis, however people with compromised immunity such as HIV, diabetes and tobacco addiction are at a higher risk to get tuberculosis. The drugs utilized to fight tuberculosis is categorized as first line treatment and second line treatment on the basis of the severity of illness. In base year 2016, first line treatment are leading the drug class segment due to factors such as rising prevalence of tuberculosis and early disease diagnosis resulting into large patients enrolled on first line treatment. Second line treatment is anticipated to register faster growth in the drug class segment throughout the forecast period 2017-2025, chiefly due to factors such as rising prevalence of MDR-TB, rising incidence of hospital acquired infection and patient’s negligence to continue first line treatment regimen. In 2016 Asia Pacific region dominated the tuberculosis treatment market due to factors such as large patient pool suffering with tuberculosis, government and non-government initiatives to eradicate tuberculosis e.g. DOTS and high disposable income in these regions. North America will register faster growth throughout the forecast period 2017-2025, chiefly due to factors such as rising public awareness regarding tuberculosis, advanced healthcare infrastructure and supportive reimbursement policies.

The tuberculosis treatment market is technologically driven and includes major players such as Pfizer Inc., Labatec Pharma SA, Eli Lilly & Co., Patheon Inc. Otsuka Novel Products GmbH, Sanofi S.A. etc. are few market leaders in tuberculosis treatment market and compete to augment their foothold in the market.

Key Market Movements:
  • Higher prevalence of tuberculosis and MDR-TB
  • Promising pipeline for the treatment of tuberculosis
  • Increasing government and non-government initiatives i.e. DOTS to eradicate tuberculosis
  • Affordable reimbursement scenario
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer Healthcare
  • Eli Lilly & Co.
  • Labatec Pharma SA
  • Mylan N.V.
  • Novatis AG
  • Patheon, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Tuberculosis Treatment Market Portraiture
2.2 Global Tuberculosis Treatment Market, by Drug Class, 2016 (US$ Mn)
2.3 Global Tuberculosis Treatment Market, by Geography, 2016 (Value %)

Chapter 3 Global Tuberculosis Treatment Market: Market Dynamics and Future Outlook
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of tuberculosis and MDR-TB
3.2.2 For a full, detailed list, browse our report
3.3 Market Restraints
3.3.1 Technological advancement in the development of tuberculosis vaccines market will hinder the tuberculosis drug market
3.3.2 For a full, detailed list, browse our report
3.4 Market Opportunities
3.4.1 Promising pipeline to overcome the drug induced resistance
3.4.2 For a full, detailed list, browse our report
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Tuberculosis Treatment Market, by Key Players

Chapter 4 Global Tuberculosis Treatment Market, by Drug Class, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 First line Treatment
4.2.1 Cytochrome P450 inhibitor (Isoniazid)
4.2.2 Mycolic acid inhibitor (Ethambutol)
4.2.3 FAS I inhibitor (Pyrazinamide)
4.2.4 RNA polymerase inhibitor (Rifampin)
4.3 Second Line Treatment
4.3.1 Mycolic acid inhibitor (Ethionamide)
4.3.2 Peptidoglycans inhibitor (Cycloserine)
4.3.3 Folic acid inhibitor (Para-amino salicylic acid)
4.3.4 30S ribosome inhibitor (Kanamycin)

Chapter 5 Global Tuberculosis Treatment Market, by Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America
5.2.1 North America Tuberculosis Treatment Market,by Drug Class, 2015-2025 (US$ Mn)
5.2.2 North America Tuberculosis Treatment Market,by Country, 2015-2025 (US$ Mn)
5.2.2.1 U.S.
5.2.2. 2 Canada
5.3 Europe
5.3.1 Europe Tuberculosis Treatment Market,by Drug Class, 2015-2025 (US$ Mn)
5.3.2 Europe Tuberculosis Treatment Market,by Country, 2015-2025 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Treatment Market, by Drug Class, 2015-2025 (US$ Mn)
5.4.2 Asia Pacific Tuberculosis Treatment Market,by Country, 2015-2025 (US$ Mn)
5.4.2.1 China
5.4.2.2 Japan
5.4.2.3 Rest of Asia Pacific
5.5 Latin America
5.5.1 Latin America Tuberculosis Treatment Market,by Drug Class, 2015-2025 (US$ Mn)
5.5.2 Latin America Tuberculosis Treatment Market,by Country, 2015-2025 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East and Africa
5.6.1 Middle East and Africa Tuberculosis Treatment Market,by Drug Class, 2015-2025 (US$ Mn)
5.6.2 Middle East and Africa Tuberculosis Treatment Market,by Country, 2015-2025 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East and Africa

Chapter 6 Company Profiles
6.1 Bayer Healthcare
6.2 Eli Lilly & Co.
6.3 Labatec Pharma SA
6.4 Macleods Pharmaceuticals Pvt Ltd.
6.5 Mylan N.V.
6.6 Novatis AG
6.7 Otsuka Novel Products GmbH
6.8 Patheon, Inc.
6.9 Pfizer, Inc.
6.10 Sanofi S.A.

List of Figures
Fig. 1 Global Tuberculosis Treatment Market: Research Methodology
Fig. 2 Global Tuberculosis Treatment Market, by Drug Class, 2016 (US$ Mn)
Fig. 3 Global Tuberculosis Treatment Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition, by Geography, 2016
Fig. 5 Market Positioning of Key Tuberculosis Treatment Vendors, 2016
Fig. 6 Isoniazid Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 7 Ethambutol Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 8 Pyrazinamide Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 9 Rifampin Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 10 Ethionamide Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 11 Cycloserine Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 12 Para-aminosalicylic acid Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 13 Kanamycin Drug Class Market, 2015 - 2025 (US$ Mn)
Fig. 14 U.S. Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 15 Canada Tuberculosis Treatment Market, 2015- 2025 (US$ Mn)
Fig. 16 U.K. Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 17 Germany Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 18 Rest of Europe Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 19 China Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 20 Japan Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 21 Rest of Asia Pacific Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 22 Brazil Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 23 Mexico Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 24 Rest of Latin America Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 25 GCC Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 26 Rest of Middle East and Africa Tuberculosis Treatment Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Tuberculosis Treatment Market, By Drug Class, 2015-2025 (US$ Mn)
Table 2 Global Tuberculosis Treatment Market, by Geography, 2015 - 2025 (US$ Mn)
Table 3 North America Tuberculosis Treatment Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 4 North America Tuberculosis Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Europe Tuberculosis Treatment Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 6 Europe Tuberculosis Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Asia Pacific Tuberculosis Treatment Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 8 Asia Pacific Tuberculosis Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Latin America Tuberculosis Treatment Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 10 Latin America Tuberculosis Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 11 Middle East and Africa Tuberculosis Treatment Market, by Drug Class, 2015 - 2025 (US$ Mn)
Table 12 Middle East and Africa Tuberculosis Treatment Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Bayer Healthcare: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 14 Eli Lilly & Co.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 15 Labatec Pharma SA: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 16 Macleods Pharmaceuticals Pvt. Ltd.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 17 Mylan N.V.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 18 Novartis AG: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 19 Otsuka Novel Products GmbH: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 20 Patheon, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 21 Pfizer, Inc.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Table 22 Sanofi S.A.: Company Snapshot (Business Description, Financial Information, Product Portfolio and News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer Healthcare
  • Eli Lilly & Co.
  • Labatec Pharma SA
  • Macleods Pharmaceuticals Pvt Ltd.
  • Mylan N.V.
  • Novatis AG
  • Otsuka Novel Products GmbH
  • Patheon, Inc.
  • Pfizer, Inc.
  • Sanofi S.A.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll